Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.

@article{Frche2002MizolastinePE,
  title={Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.},
  author={C. Fr{\`e}che and F. Leynadier and F. Horak and D. Hide and F. D. Gracia and M. Goos and C. Bachert and A. Horv{\'a}th and E. Anto{\vs}ov{\'a} and M. Verrecchia and P. B. Soussen},
  journal={Annals of allergy, asthma \& immunology : official publication of the American College of Allergy, Asthma, \& Immunology},
  year={2002},
  volume={89 3},
  pages={
          304-10
        }
}
  • C. Frèche, F. Leynadier, +8 authors P. B. Soussen
  • Published 2002
  • Medicine
  • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
BACKGROUND Mizolastine is a nonsedating H1 histamine receptor antagonist with additional antiallergic properties currently marketed in Europe for the treatment of seasonal and perennial allergic rhinitis (PAR) and urticaria. OBJECTIVE This multicenter, randomized, double-blind, parallel-group study was conducted to evaluate the efficacy and safety of mizolastine in PAR compared with loratadine and placebo. METHODS After a 1-week placebo run-in period, 428 adult PAR patients received placebo… Expand
Effects of combination of mizolastine and proteoglycan on chronic urticaria: a randomized controlled trial
Optimal Duration of Allergic Rhinitis Clinical Trials
  • J. Krouse, P. Roland, +4 authors D. Hunsaker
  • Medicine
  • Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2005
Inhibition of the histamine‐induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?
  • P. Devillier, J. Bousquet
  • Medicine
  • Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2007
Allergic rhinitis: continuous or on demand antihistamine therapy?
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
...
1
2
...

References

SHOWING 1-10 OF 29 REFERENCES
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group.
Mizolastine: a review of its use in allergic rhinitis and chronic idiopathic urticaria.
  • A. Prakash, H. Lamb
  • Medicine
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • 1998
...
1
2
3
...